Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:934659.
doi: 10.4061/2011/934659. Epub 2011 Jul 12.

The Relation between Fructose-Induced Metabolic Syndrome and Altered Renal Haemodynamic and Excretory Function in the Rat

Affiliations

The Relation between Fructose-Induced Metabolic Syndrome and Altered Renal Haemodynamic and Excretory Function in the Rat

Mohammed H Abdulla et al. Int J Nephrol. 2011.

Abstract

This paper explores the possible relationships between dietary fructose and altered neurohumoral regulation of renal haemodynamic and excretory function in this model of metabolic syndrome. Fructose consumption induces hyperinsulinemia, hypertriglyceridaemia, insulin resistance, and hypertension. The pathogenesis of fructose-induced hypertension is dubious and involves numerous pathways acting both singly and together. In addition, hyperinsulinemia and hypertension contribute significantly to progressive renal disease in fructose-fed rats. Moreover, increased activity of the renin-angiotensin and sympathetic nervous systems leading to downregulation of receptors may be responsible for the blunted vascular sensitivity to angiotensin II and catecholamines, respectively. Various approaches have been suggested to prevent the development of fructose-induced hypertension and/or metabolic alteration. In this paper, we address the role played by the renin-angiotensin and sympathetic nervous systems in the haemodynamic alterations that occur due to prolonged consumption of fructose.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The proposed mechanisms by which fructose feeding results in hypertension. BRA: baroreflex sensitivity; SNS: sympathetic nervous system; RAS: renin-angiotensin system.
Figure 2
Figure 2
(a) The effect of fructose-feeding on the renal vascular responses to adrenergic agonists and Ang II. The vascular responses, as assessed by the reduction in renal cortical blood flow (CBF) due to adrenergic agonists or Ang II intra-arterial administration (see methods), were significantly lower in fructose-fed (the gray square) compared to control (the white square) animals. (b) The effect of streptozotocin-induced diabetes on the renal vascular responses to adrenergic agonists and renal nerve stimulation. The vascular response to adrenergic stimuli as assessed by reduction in total renal blood flow (RBF) due to renal vasoconstriction was slightly lower although significant only for noradrenaline in diabetic (the gray square) compared to nondiabetic (the white square) rats. Figures are reproduced from Abdulla et al. [16] and Armenia et al. [144] respectively. Data, mean ± SEM represent the overall mean of responses to a range of doses from each agonist. Statistical analysis was performed by unpaired t-test for comparing between two groups each time, ∗ is P < 0.05 of fructose-fed versus control in (a) or diabetic versus nondiabetic in (b), (n = 6). NA: Noradrenaline; PE: phenylephrine; ME: methoxamine; RNS: renal nerve stimulation.
Figure 3
Figure 3
Proposed mechanisms that may explain the decreased vascular responses to vasoactive compounds in the fructose-fed rats. and stand for increase and decrease, respectively.

References

    1. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–1607. - PubMed
    1. Wajchenberg BL, Malerbi DA, Rocha MS, Lerario AC, Santomauro AT. Syndrome X: a syndrome of insulin resistance. Epidemiological and clinical evidence. Diabetes/Metabolism Reviews. 1994;10(1):19–29. - PubMed
    1. Hanson RL, Imperatore G, Bennett PH, Knowler WC. Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes. 2002;51(10):3120–3127. - PubMed
    1. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the san antonio heart study. Diabetes Care. 2003;26(11):3153–3159. - PubMed
    1. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683–689. - PubMed

LinkOut - more resources